Results

Total Results: 1,774 records

Showing results for "increasing".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
    March 01, 2024 - Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments Rapid Evidence Product Adverse Events Associated With COVID-19 Pharmaceutical Treatments Background and Purpose The purpose of this rapid review is to determine if COVID treatments authorized for emergency use…
  2. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
    January 01, 2007 - Layout 1 Background More than 65 million American adults— approximately one-third—have hypertension. The prevalence of hypertension increases with advancing age such that more than half of people 60-69 years of age and approximately three- fourths of those 70 years of age and older are affected. In addition to being…
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
    March 15, 2016 - treat-to-target in diabetic lipids and hypertension, when it becomes an expectation that all patients be given increasing
  4. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer_executive.pdf
    February 01, 2008 - It is not known if using higher doses of EBRT by increasing either the total amount or type of radiation … Increasing the total amount of radiation or adding brachytherapy after EBRT decreased cancer recurrence
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hro-rapid-research.pdf
    May 01, 2025 - Making Healthcare Safer IV Rapid Review: Examining the Impact of Implementing High-Reliability Organization Principles on Patient Safety Outcomes Making Healthcare Safer IV Examining the Impact of Implementing High-Reliability Organization Principles on Patient Safety Outcomes Rapid Review Structured Abs…
  6. effectivehealthcare.ahrq.gov/sites/default/files/crosscutting_hi_impact.pdf
    January 01, 2012 - Some experts noted a driver for the need is the aging population, the increasing prevalence of chronic … financially “backfire on hospitals by generating increased payer denials for medical necessity,” or by increasing
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-draft-appendi-c.xlsx
    January 01, 2024 - measure the urine volume at home every 2 to 3 months Patients did not receive any advice regarding increasing … mg QD HCTZ 25 mg QD HCTZ 50 mg QD Placebo QD NA 3 years 3 years Dietary recommendations to include increasing
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_consumer.pdf
    November 01, 2016 - Noninvasive Treatments for Low Back Pain: A Summary of the Research for Adults Noninvasive Treatments for Low Back Pain A Summary of the Research for Adults e DRAFT: CONFIDENTIAL - For review only, not for dissemination - Task 3.7c- LowBackPain_consumer - Last mod on: 15-Nov-2016, 11:04 Archived: This report i…
  9. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear_executive.pdf
    July 01, 2010 - The incidence of RC tears is related to increasing age; 54 percent of patients over the age of 60 years
  10. effectivehealthcare.ahrq.gov/sites/default/files/hawley-presentation.pdf
    May 29, 2025 -                                                 National attention  has focused  on increasing
  11. effectivehealthcare.ahrq.gov/sites/default/files/selection-of-data-sources-chapter-8.pptx
    January 01, 2013 - Slide 1 Selection of Data Sources for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Selection of Data Sources for Observational Comparative Effectiveness Research This slide set is based on a user guide titled Developing a Protocol for…
  12. effectivehealthcare.ahrq.gov/sites/default/files/exposure-definition-and-measurement_chapter-4.pptx
    January 01, 2013 - Slide 1 Exposure Definition and Measurement in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Exposure Definition and Measurement in Observational Comparative Effectiveness Research This slide set is based on a user guide titled Develop…
  13. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive.pdf
    October 01, 2006 - Layout 1 Background Renal artery stenosis (RAS) is defined as the narrowing of the lumen of the renal artery. Atherosclerosis accounts for 90 percent of cases of RAS. Atherosclerotic RAS (ARAS) is a progressive disease that may occur alone or in combination with hypertension and ischemic kidney disease. The prevalenc…
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-257-antenatal-care-evidence-summary.pdf
    June 01, 2022 - Evidence Summary_Comparative Effectiveness Review No. 257: Schedule of Visits and Televisits for Routine Antenatal Care: A Systematic Review Comparative Effectiveness Review Number 257 Schedule of Visits and Televisits for Routine Antenatal Care: A Systematic Review Evidence Summary Main Points …
  15. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - PEPTIC ULCER #11 AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 11: Peptic Ulcer Disease and Dyspepsia Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 ww…
  16. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - PEPTIC ULCER #11 AHRQ Healthcare Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 11: Peptic Ulcer Disease and Dyspepsia Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 ww…
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/gestational-diabetes-screening-diagnosis_research-protocol.pdf
    December 16, 2011 - Evidence-based Practice Center Systematic Review Protocol 1 Source: www.effectivehealthcare.ahrq.gov Published Online: December 16, 2011 Evidence-based Practice Center Systematic Review Protocol Project Title: Screening and Diagnosis of Gestational Diabetes Mellitus I. Background and Objectives for th…
  18. effectivehealthcare.ahrq.gov/sites/default/files/ch_4-user-guide-to-ocer_130129.pdf
    January 01, 2010 - 45 Abstract Characterization of exposure is a central issue in the analysis of observational data; however, no “one size fits all” solution exists for exposure measurement. In this chapter, we discuss potential exposure measurement approaches for observational comparative effectiveness research (CER). First, it is …
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_appendixes.pdf
    May 23, 2005 - the MRI exam were used to change, direct, or repeat the biopsy procedure for some of the patients, increasing … the MRI exam were used to change, direct, or repeat the biopsy procedure for some of the patients, increasing … the MRI exam were used to change, direct, or repeat the biopsy procedure for some of the patients, increasing … the MRI exam were used to change, direct, or repeat the biopsy procedure for some of the patients, increasing … of the imaging exams were used to change or direct the surgical procedure for some of the patients, increasing
  20. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
    May 01, 2010 - Layout 1 Background This report evaluates the level of evidence currently available to support the effectiveness and safety of using recombinant activated coagulation factor VII (rFVIIa) for clinical indications not approved by the U. S. Food and Drug Administration (FDA). rFVIIa is approved for a variety of uses i…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: